{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:35:47Z","timestamp":1791232547659,"version":"4.1.0"},"reference-count":8,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Hubei Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jaci.2026.06.024","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:23:33Z","timestamp":1785529413000},"page":"1158-1159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["First-trimester asthma controller medications and malformation risk: Bias, biologic plausibility, and unmeasured confounding"],"prefix":"10.1016","volume":"158","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3421-0674","authenticated-orcid":false,"given":"Zhigang","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanjun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2026.06.024_bib1","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.jaci.2026.03.013","article-title":"First-trimester asthma controller medication use and major congenital malformation risk in offspring of women with asthma: a nationwide population-based cohort study","volume":"158","author":"Jiao","year":"2026","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.024_bib2","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1016\/j.jaip.2023.07.020","article-title":"Managing asthma during pregnancy and the postpartum period","volume":"11","author":"Murphy","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2026.06.024_bib3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/bdra.23604","article-title":"Can we rely on pharmacy claims databases to ascertain maternal use of medications during pregnancy?","volume":"109","author":"Zhao","year":"2017","journal-title":"Birth Defects Res"},{"key":"10.1016\/j.jaci.2026.06.024_bib4","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/1471-0528.14026","article-title":"Risk of congenital anomalies after exposure to asthma medication in the first trimester of pregnancy \u2013 a cohort linkage study","volume":"123","author":"Garne","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.jaci.2026.06.024_bib5","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.jaci.2015.05.043","article-title":"Use of asthma medication during pregnancy and risk of specific congenital anomalies: a European case-malformed control study","volume":"136","author":"Garne","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.024_bib6","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1016\/j.jaip.2020.07.033","article-title":"Asthma medication use and risk of birth defects: National Birth Defects Prevention Study, 1997-2011","volume":"8","author":"Howley","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2026.06.024_bib7","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1097\/MLR.0000000000000800","article-title":"The impact of nondifferential exposure misclassification on the performance of propensity scores for continuous and binary outcomes: a simulation study","volume":"56","author":"Wood","year":"2018","journal-title":"Med Care"},{"key":"10.1016\/j.jaci.2026.06.024_bib8","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/bdra.22850","article-title":"Beta2-agonists use during pregnancy and the risk of congenital malformations","volume":"91","author":"Eltonsy","year":"2011","journal-title":"Birth Defects Res A Clin Mol Teratol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926004902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926004902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:58:11Z","timestamp":1791194291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674926004902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0091674926004902"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2026.06.024","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First-trimester asthma controller medications and malformation risk: Bias, biologic plausibility, and unmeasured confounding","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2026.06.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2026.03.013","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}